NCT01990898View on ClinicalTrials.gov

Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

April 30, 2016

Conditions
Interstitial Cystitis
Interventions
DRUG

Cyclosporine

Drug will be provided to patient's at study visit. Drug is to be taken twice daily. Dosage will be calculated at study visit and provided to patient.

Trial Locations (1)

44195

Cleveland Clinic - Main Campus Only, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT01990898 - Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action | Biotech Hunter | Biotech Hunter